Document is current
Any future updates will be listed below
-
Authors
Yuen, Lili https://orcid.org/0000-0002-8431-1142
Hannah, Wesley https://orcid.org/0000-0003-4163-247X
Hare, Matthew https://orcid.org/0000-0002-9364-3368
Simmons, David https://orcid.org/0000-0003-0560-0761
-
Funding
Funding for this research was provided by:
Western Sydney University
- License Information
-
More Information
Article History
Received: 13 February 2025
Accepted: 26 May 2025
First Online: 4 August 2025
Acknowledgements
: Hannah Wesley is currently an Assistant Editor at Wiley.
: Open Access funding enabled and organized by CAUL and its Member Institutions. MH is supported by the Australian Diabetes Society Skip Martin Fellowship and NHMRC Investigator Grant #1194698. LY is supported by a NSW Health PhD scholarship.
: Outside the submitted work, MH has received honoraria for lectures and consultancies from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Novo Nordisk. Outside the submitted work, DS has received educational grants from Abbott, Ascensia and Boehringer Ingelheim, devices for research and clinical service development from AMSL and Abbott, research support from Hitachi and speaker fees from Novo Nordisk and Sanofi. The authors declare that there are no other relationships or activities that might bias, or be perceived to bias, their work.
: DS conceptualised the review. All authors were involved in preparation and writing of the manuscript and the revision process and approved the final manuscript for publication.
